73 related articles for article (PubMed ID: 17513311)
1. Group additive regression models for genomic data analysis.
Luan Y; Li H
Biostatistics; 2008 Jan; 9(1):100-13. PubMed ID: 17513311
[TBL] [Abstract][Full Text] [Related]
2. Nonparametric pathway-based regression models for analysis of genomic data.
Wei Z; Li H
Biostatistics; 2007 Apr; 8(2):265-84. PubMed ID: 16772399
[TBL] [Abstract][Full Text] [Related]
3. A Markov random field model for network-based analysis of genomic data.
Wei Z; Li H
Bioinformatics; 2007 Jun; 23(12):1537-44. PubMed ID: 17483504
[TBL] [Abstract][Full Text] [Related]
4. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
5. Identification of SNP interactions using logic regression.
Schwender H; Ickstadt K
Biostatistics; 2008 Jan; 9(1):187-98. PubMed ID: 17578898
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models.
Matsui S; Ito M; Nishiyama H; Uno H; Kotani H; Watanabe J; Guilford P; Reeve A; Fukushima M; Ogawa O
Bioinformatics; 2007 Mar; 23(6):732-8. PubMed ID: 17237045
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
Decock J; Paridaens R; Ye S
Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467
[TBL] [Abstract][Full Text] [Related]
8. New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Delassus GS; Cho H; Park J; Eliceiri GL
J Cell Physiol; 2008 Dec; 217(3):739-44. PubMed ID: 18651563
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
10. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
11. Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer.
Chiu SH; Chen CC; Lin TH
Artif Intell Med; 2008 Nov; 44(3):221-31. PubMed ID: 18678474
[TBL] [Abstract][Full Text] [Related]
12. The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors.
O'Mara TA; Clements JA; Spurdle AB
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2352-65. PubMed ID: 19723913
[TBL] [Abstract][Full Text] [Related]
13. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients.
Nordgard SH; Johansen FE; Alnaes GI; Bucher E; Syvänen AC; Naume B; Børresen-Dale AL; Kristensen VN
Genes Chromosomes Cancer; 2008 Aug; 47(8):680-96. PubMed ID: 18398821
[TBL] [Abstract][Full Text] [Related]
15. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed genes by meta-analysis of microarray data on breast cancer.
Kondrakhin YV; Sharipov RN; Keld AE; Kolpakov FA
In Silico Biol; 2008; 8(5-6):383-411. PubMed ID: 19374127
[TBL] [Abstract][Full Text] [Related]
18. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
19. Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model.
Motakis E; Ivshina AV; Kuznetsov VA
IEEE Eng Med Biol Mag; 2009; 28(4):58-66. PubMed ID: 19622426
[No Abstract] [Full Text] [Related]
20. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
